Endocannabinoids and sleep

Neuroscience and Biobehavioral Reviews

Volumn 71, Issue , 2016, Pages 671-679

  Prospéro García, Oscar ^a   Amancio Belmont, Octavio ^a   Becerril Meléndez, Alline L ^a   Ruiz Contreras, Alejandra E ^b   Méndez Díaz, Mónica ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

2 AG; Anandamide; Cannabinoid system; Oleamide N acylethanolamides; Sleep waking cycle

Indexed keywords

2 ARACHIDONOYL GLYCEROL; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; ENDOCANNABINOID; LIPID; N ACYLETHANOLAMIDE; N OLEOYLETHANOLAMINE; PALMIDROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; UNCLASSIFIED DRUG; CANNABINOID RECEPTOR AFFECTING AGENT; HYPOPHYSIS HORMONE; HYPOTHALAMUS HORMONE; MELANIN; MELANIN-CONCENTRATING HORMONE;

BINDING AFFINITY; BINDING SITE; CIRCADIAN RHYTHM; DISEASE MODEL; DORSAL RAPHE NUCLEUS; DRUG TARGETING; HUMAN; INFLAMMATION; LATERAL HYPOTHALAMUS; MELANIN CONCENTRATING HORMONE NEURON; MOLECULAR DYNAMICS; NERVE CELL; NEUROMODULATION; NONHUMAN; NONREM SLEEP; PAIN; PRIORITY JOURNAL; REM SLEEP; REVIEW; SATIETY; SLEEP; SLEEP MODULATION; SLEEP WAKING CYCLE; WAKE MODULATION; WAKEFULNESS; ANIMAL; METABOLISM;

ANIMALS; CANNABINOID RECEPTOR MODULATORS; ENDOCANNABINOIDS; HYPOTHALAMIC HORMONES; MELANINS; PITUITARY HORMONES;

EID: 84994013408     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2016.10.005     Document Type: Review

References (66)

1. American Academy of Sleep Medicine, International Classification of Sleep Disorders. 3er. edition, 2015.
2. Basile, A.S., Hanus, L., Mendelson, W.B., Characterization of the hypnotic properties of oleamide. Neuror 10 (1999), 947–951.
3. Belendiuk, K.A., Babson, K.A., Vandrey, R., Bonn-Miller, M.O., Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users. Addict. Behav. 50 (2015), 178–181.
4. Bonn-Miller, M.O., Babson, K.A., Vandrey, R., Using cannabis to help you sleep: heightened frequency of medical cannabis use among those with PTSD. Drug Alcohol Depend. 136 (2014), 162–165.
5. Boyce, R., Glasgow, S.D., Williams, S., Adamantidis, A., Causal evidence for the role of REM sleep theta rhythm in contextual memory consolidation. Science 352 (2016), 812–816.
6. Cai, D.J., Shuman, T., Gorman, M.R., Sage, J.R., Anagnostaras, S.G., Sleep selectively enhances hippocampus-dependent memory in mice. Behav. Neurosci. 123 (2009), 713–719.
7. Cravatt, B.F., Prospero-Garcia, O., Siuzdak, G., Gilula, N.B., Chemical characterization of a family of brain lipids that induce sleep. Science, 268, 1995, 1506.
8. Di Marzo, V., Piscitelli, F., The endocannabinoid system and its modulation by phytocannabinoids. Neurotherapeutics 12 (2015), 692–698.
9. Edelman, G.M., Wider than The Sky: The Phenomenal Gift of Consciousness. 2005, Yale Universe Press, New Haven, USA.
10. Engeli, S., Blüher, M., Jumpertz, R., Wiesner, T., Wirtz, H., Bosse-Henck, A., Stumvoll, M., Batkai, S., Pacher, P., Harvey-White, J., Kunos, G., Jordan, J., Circulating anandamide and blood pressure in patients with obstructive sleep apnea. Rheumatol. Int. 32 (2012), 2593–2599.
11. Garcia-Rill, E., Luster, B., D'Onofrio, S., Mahaffey, S., Bisagno, V., Urbano, F.J., Implications of gamma band activity in the pedunculopontine nucleus. J. Neural Transm. (Vienna) 123 (2016), 655–665.
12. Gates, P.J., Albertella, L., Copeland, J., The effects of cannabinoid administration on sleep: a systematic review of human studies. Sleep Med. Rev. 18 (2014), 477–487.
13. Goonawardena, A.V., Plano, A., Robinson, L., Ross, R., Greig, I., Pertwee, R.G., Hampson, R.E., Platt, B., Riedel, G., Modulation of food consumption and sleep-wake cycle in mice by the neutral CB1 antagonist ABD459. Behav. Pharmacol. 26 (2015), 289–303.
14. Hanlon, E.C., Tasali, E., Leproult, R., Stuhr, K.L., Doncheck, E., De Wit, H., Hillard, C.J., Van Cauter, E., Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol. J. Clin. Endocrinol. Metab. 100 (2014), 220–226.
15. Hashimotodani, Y., Ohno-Shosaku, T., Yamazaki, M., Sakimura, K., Kano, M., Neuronal protease-activated receptor 1 drives synaptic retrograde signaling mediated by the endocannabinoid 2-arachidonoylglycerol. J. Neurosci. 31 (2011), 3104–3109.
16. Herrera-Solís, A., Vásquez, K.G., Prospéro-García, O., Acute and subchronic administration of anandamide or oleamide increases REM sleep in rats. Pharmacol. Biochem. Behav. 95 (2010), 106–112.
17. Hobson, A., Voss, U., A mind to go out of: reflections on primary and secondary consciousness. Conscious. Cogn. 20 (2011), 993–997.
18. Hofer, M.A., The organization of sleep and wakefulness after maternal separation in young rats. Dev. Psychobiol. 9 (1976), 189–205.
19. Huitron-Resendiz, S., Sanchez-Alavez, M., Wills, D.N., Cravatt, B.F., Henriksen, S.J., Characterization of the sleep-wake patterns in mice lacking fatty acid amide hydrolase. Sleep 27 (2004), 857–865.
20. Iannotti, F.A., Di Marzo, V., Petrosino, S., Endocannabinoids and endocannabinoid-related mediators targets, metabolism and role in neurological disorders. Prog. Lipid Res. 62 (2016), 107–128.
21. Jumpertz, R., Wiesner, T., Blüher, M., Engeli, S., Bátkai, S., Wirtz, H., Bosse-Henck, A., Stumvoll, M., Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea?specific role of oleoylethanolamide. Expand Clin. Endocrinol. Diab. 118 (2010), 591–595.
22. Juszczak, G.R., Swiergiel, A.H., Properties of gap junction blockers and their behavioural: cognitive and electrophysiological effects: animal and human studies. Prog. Neuropsychopharmacol. Biol. Psychiatry 33 (2009), 181–198.
23. Koch, M., Ferreirós, N., Geisslinger, G., Dehghani, F., Korf, H.W., Rhythmic control of endocannabinoids in the rat pineal gland. Chronobiol. Int. 32 (2015), 869–874.
24. Koethe, D., Schreiber, D., Giuffrida, A., Mauss, C., Faulhaber, J., Heydenreich, B., Hellmich, M., Graf, R., Klosterkötter, J., Piomelli, D., Leweke, F.M., Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid. J. Neural Transm. (Vienna). 116 (2009), 301–305.
25. Kovács, A., Bordás, C., Pál, B., Cholinergic and endocannabinoid neuromodulatory effects overlap on neurons of the pedunculopontine nucleus of mice. Neuror 26 (2015), 273–278.
26. Kumar, S., Rai, S., Hsieh, K.C., McGinty, D., Alam, M.N., Szymusiak, R., Adenosine A(2A) receptors regulate the activity of sleep regulatory GABAergic neurons in the preoptic hypothalamus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 305 (2013), R31–R41.
27. Lambás-Señas, L., Mnie-Filali, O., Certin, V., Faure, C., Lemoine, L., Zimmer, L., Haddjeri, N., Functional correlates for 5-HT 1A receptors in maternally deprived rats displaying anxiety and depression-like behaviors. Prog. Neuropsychopharmacol. Biol. Psychiatry. 33 (2009), 262–268.
28. Lerner, R.A., Siuzdak, G., Prospero-Garcia, O., Henriksen, S.J., Boger, D.L., Cravatt, B.F., Cerebrodiene: a brain lipid isolated from sleep-deprived cats. Proc. Natl. Acad. Sci. U. S. A. 91 (1994), 9505–9508.
29. Luppi, P.H., Fort, P., Neurochemistry of sleep an overview of animal experimental work. Handb. Clin. Neurol. 98 (2011), 173–190.
30. Martinez-Vargas, M., Murillo-Rodriguez, E., Gonzalez-Rivera, R., Landa, A., Mendez-Daz, M., Prospero-Garcia, O., Navarro, L., Sleep modulates cannabinoid receptor 1 expression in the pons of rats. Neuroscience 117 (2003), 197–201.
31. Martinez-Vargas, M., Morales-Gomez, J., Gonzalez-Rivera, R., Hernandez-Enriquez, C., Perez-Arredondo, A., Estrada-Rojo, F., Navarro, L., Does the neuroprotective role of anandamide display diurnal variations?. Int. J. Mol. Sci. 14 (2013), 23341–23355.
32. McCarley, R.W., Neurobiology of REM sleep. Handb. Clin. Neurol. 98 (2011), 151–171.
33. Mechoulam, R., Fride, E., Hanu, L., Sheskin, T., Bisogno, T., Di Marzo, V., Bayewitch, M., Vogel, Z., Anandamide may mediate sleep induction. Nature 389 (1997), 25–26.
34. Mendelson, W.B., Basile, A.S., The hypnotic actions of oleamide are blocked by a cannabinoid receptor antagonist. Neuror 10 (1999), 3237–3239.
35. Mueller, G.P., Driscoll, W.J., Biosynthesis of oleamide. Vitam Horm. 81 (2009), 55–78.
36. Murillo-Rodríguez, E., Cabeza, R., Méndez-Díaz, M., Navarro, L., Prospéro-García, O., Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor. Neuroreport 12 (2001), 2131–2136.
37. Murillo-Rodrı́guez, E., Sánchez-Alavez, M., Navarro, L., Martınez-Gonzalez, D., Drucker-Colın, R., Prospero-Garcıa, O., Anandamide modulates sleep and memory in rats. Brain Res. 812 (1998), 270–274.
38. Murillo-Rodriguez, E., Blanco-Centurion, C., Sanchez, C., Piomelli, D., Shiromani, P.J., Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study. Sleep 26 (2003), 943–947.
39. Murillo-Rodriguez, E., Désarnaud, F., Prospéro-García, O., Diurnal variation of arachidonoylethanolamine, palmitoylethanolamide and oleoylethanolamide in the brain of the rat. Life Sci. 79 (2006), 30–37.
40. Murillo-Rodriguez, E., Poot-Ake, A., Arias-Carrion, O., Pacheco-Pantoja, E., Fuente-Ortegon Ade, L., Arankowsky-Sandoval, G., The emerging role of the endocannabinoid system in the sleep-wake cycle modulation. Cent. Nerv. Syst. Agents Med. Chem. 11 (2011), 189–196.
41. Navarro, L., Martínez-Vargas, M., Murillo-Rodríguez, E., Landa, A., Méndez-Díaz, M., Prospéro-García, O., Potential role of the cannabinoid receptor CB1 in rapid eye movement sleep rebound. Neurosci 120 (2003), 855–859.
42. Pérez-Morales, M., Alvarado-Capuleno, I., Lopez-Colome, A.M., Mendez-Diaz, M., Ruiz-Contreras, A.E., Prospéro-García, O., Activation of PAR1 in the lateral hypothalamus of rats enhances food intake and REMS through CB1R. Neuroreport 23 (2012), 814–818.
43. Perron, R.R., Tyson, R.L., Sutherland, G.R., Delta-9- Tetrahydrocannabinol increases brain temperature and inverts circadian rhythms. NeuroReport 12 (2001), 3791–3794.
44. Pérez-Morales, M., Alberto, K., Méndez-Díaz, M., Ruiz-Contreras, A.E., Drucker-Colín, R., Prospéro-García, O., 2-AG into the lateral hypothalamus increases REM sleep and cFos expression in melanin concentrating hormone neurons in rats. Pharmacol. Biochem. Behav. 108 (2013), 1–7.
45. Pérez-Morales, M., Fajardo-Valdez, A., Méndez-Díaz, M., Ruiz-Contreras, A.E., Prospéro-García, O., 2-Arachidonoylglycerol into the lateral hypothalamus improves reduced sleep in adult rats subjected to maternal separation. Neuroreport 25 (2014), 1437–1441.
46. Pérez-Morales, M., López-Colomé, A.M., Méndez-Díaz, M., Ruiz-Contreras, A.E., Prospéro-García, O., Inhibition of diacylglycerol lipase (DAGL) in the lateral hypothalamus of rats prevents the increase in REMS and food ingestion induced by PAR1 stimulation. Neurosci. Lett. 578 (2014), 117–121.
47. Pava, M.J., den Hartog, C.R., Blanco-Centurion, C., Shiromani, P.J., Woodward, J.J., Endocannabinoid modulation of cortical up-states and NREM sleep. PLoS One, 9, 2014, e88672.
48. Prospéro-García, O., Cravatt, B.E., Siuzdak, G., Boger, D.L., Lerner, R., Henriksen, S., cis-9, 10 Octadecenoamide: a novel natural lipid isolated from cat CSF with potential sleep-modulating properties. Sleep Res., 24, 1995, 50.
49. Reyes-Prieto, N.M., Romano-López, A., Pérez-Morales, M., Pech, O., Méndez-Díaz, M., Ruiz-Contreras, A.E., Prospéro-García, O., Oleamide restores sleep in adult rats that were subjected to maternal separation. Pharmacol. Biochem. Behav. 103 (2012), 308–312.
50. Rueda-Orozco, P.E., Soria-Gómez, E., Montes-Rodríguez, C.J., Pérez-Morales, M., Prospéro-García, O., Intrahippocampal administration of anandamide increases REM sleep. Neurosci. Lett. 473 (2010), 158–162.
51. Sanford, A.E., Castillo, E., Gannon, R.L., Cannabinoids and hamster circadian activity rhythms. Brain Res. 1222 (2008), 141–148.
52. Santucci, V., Storme, J.J., Soubrié, P., Le Fur, G., Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis. Life Sci. 58 (1996), PL103–PL110.
53. Shiromani, P.J., Armstrong, D.M., Gillin, J.C., Cholinergic neurons from the dorsolateral pons project to the medial pons: a WGA-HRP and choline acetyltransferase immunohistochemical study. Neurosci. Lett. 95 (1988), 19–23.
54. Siegel, J.M., The neurobiology of sleep. Semin. Neurol. 29 (2009), 277–296.
55. Silvani, A., Berteotti, C., Bastianini, S., Martire, V.L., Mazza, R., Pagotto, U., Quarta, C., Zoccoli, G., Multiple sleep alterations in mice lacking cannabinoid type 1 receptors. PLoS One, 9, 2014, e89432.
56. Soni, N., Kohlmeier, K.A., Endocannabinoid CB1 receptor-mediated rises in Ca2+ and depolarization-induced suppression of inhibition within the laterodorsal tegmental nucleus. Brain Struct. Funct., 2015, 1–23.
57. Soria-Gómez, E., Guzmán, K., Pech-Rueda, O., Montes-Rodríguez, C.J., Cisneros, M., Prospéro-García, O., Oleoylethanolamide affects food intake and sleep–waking cycle through a hypothalamic modulation. Pharmacol. Res. 61:5 (2010), 379–384.
58. Stickgold, R., Parsing the role of sleep in memory processing. Curr. Opin. Neurobiol. 23 (2013), 847–853.
59. Takao, K., Noguchi, K., Hashimoto, Y., Shirahata, A., Sugita, Y., Synthesis and evaluation of fatty acid amides on the N-oleoylethanolamide-like activation of peroxisome proliferator activated receptor α. Chem. Pharm. Bull. 63 (2015), 278–285.
60. Valenti, M., Vigano, D., Casico, M.G., Rubino, T., Steardo, L., Parolaro, D., Di Marzo, V., Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain. Cell. Mol. Life Sci. 61 (2004), 945–950.
61. Van Dort, C.J., Brown, E.N., Reply to Grace: role of cholinergic neurons in rapid eye movement (REM) sleep control. Proc. Natl. Acad. Sci., 112, 2015 E3756-E3756.
62. Van Gaal, L.F., Rissanen, A.M., Scheen, A.J., Ziegler, O., Rössner, S., RIO-Europe Study Group, Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 365 (2005), 1389–1397.
63. Vaughn, L.K., Denning, G., Stuhr, K.L., de Wit, H., Hill, M.N., Hillard, C.J., Endocannabinoid signalling: has it got rhythm?. Br. J. Pharmacol. 160 (2010), 530–543.
64. Verret, L., Goutagny, R., Fort, P., Cagnon, L., Salvert, D., Léger, L., Boissard, R., Salin, P., Peyron, C., Luppi, P.H., A role for melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep. BMC Neurosci. 9 (2003), 4–19.
65. Wang, X., Yu, Q., Yue, H., Zhang, J., Zeng, S., Cui, F., Circulating endocannabinoids and insulin resistance in patients with obstructive sleep apnea. BioMed Res. Int., 2016, 2016, 9782031.
66. Yang, J.Y., Wu, C.F., Wang, F., Song, H.R., Pan, W.J., Wang, Y.L., The serotonergic system may be involved in the sleep-inducing action of oleamide in rats. Naunyn. Schmiedebergs Arch. Pharmacol. 368 (2003), 457–462.